Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Ghana

Type of support

Approvals

2001-2021 (US$)

(18 Oct 2017)

Commitments

2001-2021 (US$)

(18 Oct 2017)

Disbursements

2000-2017 (US$)

(18 Oct 2017)

% Disbursed

(18 Oct 2017)

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Total

$265,622,333

$281,047,983

$262,319,588

Cash Support (CASHSUPP)

$170,000

$195,000

$170,000

100%

Civil Society Organisation support (CSO)

$765,000

$765,000

$832,909

109%

Health system strengthening (HSS 1)

$9,670,000

$9,670,000

$9,032,898

93%

Health system strengthening (HSS 2)

$11,179,146

$18,059,296

$7,739,496

69%

HPV Demo (NVS)

$188,885

$188,885

$190,108

101%

Immunisation services support (ISS)

$5,316,620

$5,316,620

$5,316,620

100%

Injection Safety Devices (NVS)

$462,500

$829,000

$587,102

127%

Injection safety support (INS)

$855,300

$855,300

$855,300

100%

IPV (NVS)

$54,268

$54,268

$54,268

100%

Measles (NVS)

$1,711,336

$1,711,336

$1,711,336

100%

Measles-Rubella (NVS)

$7,750,269

$7,750,269

$7,750,269

100%

Meningitis A (NVS)

$1,078,048

$2,351,548

$1,121,926

104%

Meningitis A - campaign (NVS)

$2,037,743

$2,037,743

$2,037,743

100%

Meningitis A - mini catch-up campaign (NVS)

$635,266

$635,266

$635,266

100%

Meningitis A - mini catch-up op.costs (OPC)

$524,500

$524,500

$524,500

100%

Meningitis A - operational costs (OPC)

$1,949,753

$1,949,753

$1,949,753

100%

MR - Operational costs (OPC)

$7,522,000

$7,522,000

$7,522,000

100%

Penta (NVS)

$95,644,272

$100,614,272

$96,494,583

101%

Pneumo (NVS)

$79,702,070

$79,702,070

$80,485,450

101%

Rotavirus (NVS)

$23,783,350

$23,783,350

$22,482,161

95%

Vaccine Introduction Grant (VIG)

$3,448,500

$3,448,500

$3,448,500

100%

Yellow Fever (NVS)

$11,173,507

$13,084,007

$11,377,400

102%

Red line on table indicates duration of support based on commitments.Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.Approvals: Total Approved for funding

News and updates relating to Ghana

Ahead of Seth Berkley’s speech to the 2017 graduating class at Johns Hopkins University in Washington, DC on 23 June, Global Health published a two-part Q&A with the Gavi CEO. In this second article, Seth shares his concerns about the expansion of the vaccine hesitancy movement, explains why digital identity technologies in low- and middle-income countries can help improve vaccine coverage, and discusses the value of testing the potentially important malaria vaccine.